Selected article for: "apoptotic cell and cell activation"

Author: Chilunda, Vanessa; Martinez-Aguado, Pablo; Xia, Li C.; Cheney, Laura; Murphy, Aniella; Veksler, Veronica; Ruiz, Vanessa; Calderon, Tina M.; Berman, Joan W.
Title: Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19
  • Cord-id: xo09qwpv
  • Document date: 2021_5_24
  • ID: xo09qwpv
    Snippet: The COVID-19 pandemic has caused more than three million deaths globally. The severity of the disease is characterized, in part, by a dysregulated immune response. CD16+ monocytes are innate immune cells involved in inflammatory responses to viral infections, and tissue repair, among other functions. We characterized the transcriptional changes in CD16+ monocytes from PBMC of people with COVID-19, and from healthy individuals using publicly available single cell RNA sequencing data. CD16+ monocy
    Document: The COVID-19 pandemic has caused more than three million deaths globally. The severity of the disease is characterized, in part, by a dysregulated immune response. CD16+ monocytes are innate immune cells involved in inflammatory responses to viral infections, and tissue repair, among other functions. We characterized the transcriptional changes in CD16+ monocytes from PBMC of people with COVID-19, and from healthy individuals using publicly available single cell RNA sequencing data. CD16+ monocytes from people with COVID-19 compared to those from healthy individuals expressed transcriptional changes indicative of increased cell activation, and induction of a migratory phenotype. We also analyzed COVID-19 cases based on severity of the disease and found that mild cases were characterized by upregulation of interferon response and MHC class II related genes, whereas the severe cases had dysregulated expression of mitochondrial and antigen presentation genes, and upregulated inflammatory, cell movement, and apoptotic gene signatures. These results suggest that CD16+ monocytes in people with COVID-19 contribute to a dysregulated host response characterized by decreased antigen presentation, and an elevated inflammatory response with increased monocytic infiltration into tissues. Our results show that there are transcriptomic changes in CD16+ monocytes that may impact the functions of these cells, contributing to the pathogenesis and severity of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • access number and acute respiratory distress syndrome: 1
    • access number and low number: 1, 2, 3, 4, 5
    • accession number and activation gene: 1
    • accession number and acute respiratory: 1, 2, 3, 4, 5
    • accession number and log fold change: 1, 2
    • accession number and low number: 1
    • activation gene and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • activation gene and acute respiratory distress syndrome: 1
    • activation gene and adhesion molecule: 1, 2, 3
    • activation gene and local inflammation: 1
    • activation signal and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • activation signal and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
    • activation signal and adhesion molecule: 1
    • activation signal and local inflammation: 1
    • acute respiratory and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and adhesion molecule expression: 1, 2, 3, 4, 5
    • acute respiratory and local inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and longitudinal sample: 1, 2, 3, 4, 5, 6
    • acute respiratory and low monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9